Bailey T. et al. Diabetes Technology Ther. 2015, 17(11), 1-8

9. Kuwa K, Nakayama T, Hoshino T, Tominaga M: Re- lationships of glucose concentrations in capillary whole blood, venous whole blood and venous plasma. Clin Chim Acta 2001;307:187–192. 10. Tonyushkina K, Nichols JH: Glucose meters: a review of technical challenges to obtaining accurate results. J Dia- betes Sci Technol 2009;3:971–980. 11. Shivers JP, Mackowiak L, Anhalt H, Zisser H. ‘‘Turn it off!’’: diabetes device alarm fatigue considerations for the present and the future. J Diabetes Sci Technol 2013;7:789–794. 12. Rossetti P, Bondia J, Vehı´ J, Fanelli CG: Estimating plasma glucose from interstitial glucose: the issue of calibration algorithms in commercial continuous glucose monitoring devices. Sensors (Basel) 2010;10:10936–10952. 13. New JP, Ajjan R, Pfeiffer AFH, Freckmann G: Continuous glucose monitoring in people with diabetes: the randomized controlled Glucose Level Awareness in Diabetes Study (GLADIS). Diabet Med 2015;32:609–617. 14. Rebrin K, Sheppard NF Jr, Steil GM: Use of subcutaneous interstitial fluid glucose to estimate blood glucose: revisit- ing delay and sensor offset. J Diabetes Sci Technol 2010; 4:1087–1098. 15. Castle JR, Ward WK: Amperometric glucose sensors: sources of error and potential benefit of redundancy. J Diabetes Sci Technol 2010;4:221–225. 16. Mazze RS, Strock E, Borgman S, Wesley D, Stout P, Racchini J: Evaluating the accuracy, reliability, and clinical applicability of continuous glucose monitoring (CGM): is CGM ready for real time? Diabetes Technol Ther 2009;11: 11–18. 17. Bailey T, Zisser H, Chang A: New features and performance of a next-generation SEVEN-day continuous glucose mon- itoring system with short lag time. Diabetes Technol Ther 2009;11:749–755. 18. Michaud C, Cengiz E, Tamborlane WV, Carria LR, Wein- zimer SA: Warming up to sensors: does site warming improve continuous glucose monitoring performance? [abstract]. Diabetes 2014;63(Suppl 1):870-P. 19. Cengiz E, Tamborlane VW: A tale of two compartments: interstitial versus blood glucose monitoring. Diabetes Technol Ther 2009;11(Suppl 1):S-11–S-16. 20. Lodwig V, Heinemann L; Glucose Monitoring Study Group: Continuous glucose monitoring with glucose assess- ment criteria. Diabetes Technol Ther 2003;5:572–586. 21. Kempe K, Price D, Ellison J, Marhoul J, Morrow L, Win K, Kuschma K, Hompesch M: Capillary and venous blood glucose concentrations measured during intravenous insulin and glucose infusion: a comparison of steady and dynamic states. Diabetes Technol Ther 2009;11:669–674. 22. Colaguri S, Sandbaek A, Carstensen B, Christensen J, Glumert C, Lauritzen T, Borch-Johnsen K: Comparability of venous and capillary glucose measurements in blood. Diabet Med 2003;20:953–956. 23. Clinical and Laboratory Standards Institute: Glucose Mon- itoring in Settings Without Laboratory Support; Approved Guideline—Second Edition. CLSI document AST4-A2 Wayne, PA: Clinical and Laboratory Standards Institute, 2005. 24. Hoss U, Budiman ES, Liu H, Christiansen MP: Continuous glucose monitoring in the subcutaneous tissue over a 14- day sensor wear period. J Diabetes Sci Technol 2013;7: 1210–1219. 25. Hoss U, Budiman ES, Liu H, Christiansen MP: Feasibility of factory calibration for subcutaneous glucose sensors in subjects with diabetes. J Diabetes Sci Technol 2014;8:89–94. 26. Ward KW: A review of the foreign-body response to sub- cutaneously-implanted devices: the role of macrophages and cytokines in biofouling and fibrosis. J Diabetes Sci Technol 2008;2:768–777. 27. Weinstein RL, Schwartz SL, Brazg RL, Bugler JR, Peyser A, McGarraugh GV: Accuracy of the 5-Day FreeStyle Navigator continuous glucose monitoring system. Diabetes Care 2007;30:1125–1130. 28. JDRF Continuous Glucose Monitoring Study Group: The effect of continuous glucose monitoring in well-controlled type 1 diabetes. Diabetes Care 2009;32:1378–1383. 29. Danne T, de Valk HW, Kracht KW, Geldmacher R, So¨lter L, von dem Berge W, Welsh ZK, Bugler JR, Lange K, Kordo- nouri O: Reducing glycaemic variability in type 1 diabetes self-management with a continuous glucose monitoring sys- tem based on wired enzyme technology. Diabetologia 2009; 52:1496–1503. 30. Hirsch IB, Abelseth J, Bode BW, Fischer JS, Kaufman FR, Mastrototaro J, Parkin CG, Wolpert HA, Buckingham BA: Sensor-augmented insulin pump therapy: Results of the first randomized treat-to-target study STAR-1. Diabetes Tech- nol Ther 2008;10:377–383. 31. Bergenstal RM, Tamborlane WV, Ahmann A, Buse JB, Dailey G, Davis SN, Joyce C, Peoples T, Perkins BA, Welsh JB, Willi SM, Wood MA; STAR 3 Study Group: Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes. N Engl J Med 2010;363:311–320. Erratum in N Engl J Med 2010;363:1092. 32. Battelino T, Phillip M, Bratina N, Nimri R, Oskarsson P, Bolinder J: Effect of continuous glucose monitoring on hypoglycemia in type 1 diabetes. Diabetes Care 2011;34: 795–800. Address correspondence to: Shridhara Alva, PhD Clinical Affairs Abbott Diabetes Care 1360 South Loop Road Alameda, CA 94502 E-mail: Shridhara.alva@abbott.com 8 BAILEY ET AL.

Seitenübersicht